Fulgent Genetics (FLGT) Change in Acquisitions & Divestments (2017 - 2026)
Fulgent Genetics' Change in Acquisitions & Divestments history spans 10 years, with the latest figure at $81.7 million for Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 151.84% to $81.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $260.3 million, a 9.25% decrease, with the full-year FY2025 number at $211.0 million, down 39.68% from a year prior.
- Change in Acquisitions & Divestments hit $81.7 million in Q1 2026 for Fulgent Genetics, up from $78.1 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for FLGT hit a ceiling of $141.4 million in Q1 2023 and a floor of $27.8 million in Q1 2022.
- Historically, Change in Acquisitions & Divestments has averaged $81.4 million across 5 years, with a median of $78.1 million in 2025.
- Biggest five-year swings in Change in Acquisitions & Divestments: skyrocketed 409.39% in 2023 and later plummeted 66.01% in 2025.
- Tracing FLGT's Change in Acquisitions & Divestments over 5 years: stood at $100.8 million in 2022, then surged by 30.6% to $131.7 million in 2023, then plummeted by 45.48% to $71.8 million in 2024, then increased by 8.79% to $78.1 million in 2025, then rose by 4.63% to $81.7 million in 2026.
- Business Quant data shows Change in Acquisitions & Divestments for FLGT at $81.7 million in Q1 2026, $78.1 million in Q4 2025, and $40.2 million in Q3 2025.